We previously reported that vaccination with a CTLA4-PD-L1 DNA cancer vaccine induced endogenous antibodies against CTLA-4 and PD-L1, and inhibited the tumor growth in a spontaneous TAA-induced rat iCCA model (29). This evidence concerns the gene CTLA4 and neoplasm.